If you take a blood-pressure or heart medication, check the drug name, NDC number and lot on your bottle against the recalls below — but do not stop taking anything without talking to your doctor or pharmacist first.
What Is Being Recalled?
Three separate heart and blood-pressure medications were recalled in June 2026, and coverage that lumps them together under a single "FDA recalls heart and blood pressure drugs" headline can make them look like one giant recall. They are not — they are three distinct Class II recalls of three different drugs, made by three different manufacturers, for three different reasons. All are recorded in the FDA's Enforcement Reports, and all are pharmacy- and wholesale-level recalls: there is no consumer claim form and nothing to file.The one drawing the most attention is a recall of chlorthalidone, a common blood-pressure water pill, distributed by Rising Pharma Holdings and manufactured by Inventia Healthcare, over a failed dissolution test. Alongside it, the same distributor recalled a batch of the ACE inhibitor enalapril, and Amgen separately recalled its heart drug Corlanor. Here is what each one involves.
1. Chlorthalidone 25 mg (the Inventia / Rising Pharma Recall)
Chlorthalidone is a thiazide-like diuretic — a "water pill" widely prescribed to lower blood pressure. Rising Pharma Holdings, Inc., of East Brunswick, New Jersey, is recalling 11,460 bottles of Chlorthalidone Tablets, USP, 25 mg, that were manufactured by Inventia Healthcare Limited in India. The affected stock is 100-count bottles under NDC 64980-599-01 (batch RISA24001) and 1,000-count bottles under NDC 64980-599-10 (batch RISB24002), with an April 2027 expiration, distributed nationwide.The reason is a failed dissolution specification — in testing, the tablets did not dissolve within the required range. Dissolution controls how quickly and completely a tablet releases its active ingredient, so a chlorthalidone tablet that dissolves too slowly could deliver less medicine than intended. For a blood-pressure drug, the practical concern is reduced effectiveness — blood pressure that is not as well controlled — rather than a toxic exposure. The FDA classified it as a Class II recall on June 22, 2026, after Rising Pharma initiated it on June 5, 2026.
2. Enalapril Maleate 20 mg (an ACE Inhibitor)
Separately, Rising Pharma is also recalling a lot of Enalapril Maleate Tablets, USP, 20 mg — an ACE inhibitor used for high blood pressure and heart failure (why it shows up under both "blood pressure" and "heart" headlines). The recalled lot, GEH25023 (NDC 64980-688-10), is 675 bottles of 1,000 tablets, expiration June 30, 2027, distributed nationwide. It was made by Unique Pharmaceutical Laboratories, a division of J.B. Chemicals & Pharmaceuticals Ltd.This recall is over a failed organic-impurities test — an out-of-specification impurity result. Importantly, the specific impurity has not been publicly identified, and no FDA source has described it as a nitrosamine, so this is not the nitrosamine-contamination story that drove the well-known valsartan and losartan recalls. It is a distinct Class II recall that began April 23, 2026.
3. Corlanor (Ivabradine), by Amgen
The third recall is different again. Amgen issued a voluntary nationwide recall of Corlanor (ivabradine) 5 mg and 7.5 mg tablets — a medication that slows the heart rate in certain heart-failure patients — over the presence of a foreign substance. That recall started June 4, 2026 and is also Class II. Ivabradine is a heart-rate drug rather than a blood-pressure drug, but it lands in the same June 2026 news cycle, which is why it often appears in the same roundups.What Should Patients Do?
The most important thing is what not to do: do not stop taking a blood-pressure or heart medication on your own. Abruptly stopping these drugs can be more dangerous than the recall itself. Instead, look at your bottle. Each recall is tied to specific NDC numbers and lot/batch numbers printed on the label — check whether yours matches one listed above. If it does, contact your pharmacy; pharmacies can typically replace an affected bottle at no cost, and your prescriber can advise if anything about your regimen should change.Because these are pharmacy- and wholesale-level recalls (large stock bottles of 100 and 1,000 tablets, not retail consumer packaging), most patients will hear about an affected bottle from their pharmacy rather than needing to act first. There is no settlement, no refund program, and no claim form attached to any of these three recalls.
Is This the Same as the Valsartan and Losartan Recalls?
No. The valsartan, losartan, and irbesartan recalls that led to years of litigation involved a different class of drug — angiotensin II receptor blockers (ARBs) — recalled because of nitrosamine contamination (NDMA and NDEA), which are probable carcinogens. None of the June 2026 recalls here is an ARB, and none has been attributed to nitrosamines: chlorthalidone is a diuretic recalled for a dissolution failure, enalapril is an ACE inhibitor recalled for an unspecified impurity, and ivabradine is a heart-rate drug recalled for a foreign substance. If you are looking for the nitrosamine cases, those are covered on our valsartan, losartan and irbesartan contamination settlement page, which is a separate matter.Frequently Asked Questions
Which blood pressure and heart medications were recalled in June 2026?
Three separate products: chlorthalidone 25 mg tablets (a diuretic, distributed by Rising Pharma, made by Inventia Healthcare) recalled for failing a dissolution test; enalapril maleate 20 mg tablets (an ACE inhibitor, also distributed by Rising Pharma) recalled for failing an organic-impurities test; and Corlanor (ivabradine) 5 mg and 7.5 mg (Amgen), recalled over a foreign substance. All three are Class II recalls.
Should I stop taking my medication?
No — do not stop taking a blood-pressure or heart medication on your own. Suddenly stopping can be dangerous. Check the drug name, NDC number and lot number on your bottle against the recall, and talk to your pharmacist or doctor, who can replace an affected bottle or adjust your prescription.
Is there a refund or claim form for these recalls?
No. These are pharmacy- and wholesale-level recalls, not settlements. There is no consumer claim form and no settlement administrator. If your bottle is affected, your pharmacy can typically replace it at no cost — ask the pharmacist.
Are these the same as the valsartan and losartan recalls?
No. Valsartan, losartan and irbesartan are ARBs recalled over nitrosamine contamination. The June 2026 recalls involve different drugs — a diuretic (chlorthalidone), an ACE inhibitor (enalapril) and a heart-rate drug (ivabradine) — and different reasons (a dissolution failure, an unspecified impurity, and a foreign substance). The specific enalapril impurity has not been publicly identified, and no source has called it a nitrosamine.
What does a Class II recall mean?
Class II is the FDA's middle recall category. It means use of the product may cause temporary or medically reversible health effects, and the chance of serious harm is remote. It is less severe than Class I (reasonable probability of serious harm or death) and more serious than Class III.
Sources
- FDA Enforcement Reports Database (search by firm or NDC)
- FDA — Recalls, Market Withdrawals & Safety Alerts
- TODAY — Chlorthalidone Blood-Pressure Recall Classified Class II
- Fox Business — Thousands of Bottles of Blood-Pressure Medication Recalled Nationwide
Free settlement alerts
Get notified when new class actions open to claims
Join thousands of readers who get the latest class action settlements you may qualify for — delivered straight to your inbox.
